Jump to content



Photo

Article: 2013 Global Sales -- Cymbalta #9 @ $6.46 Billion; Lilly #10 Total Sales @ $ $23 Billion


  • Please log in to reply
3 replies to this topic

#1 FiveNotions

FiveNotions

    God-like

  • Active Members
  • PipPipPipPipPipPipPipPip
  • 3,686 posts
  • LocationUS, East Coast
  • why_joining:
    I want my life back!

Posted 16 September 2014 - 08:33 PM

2013 Statistics for Global Prescription Medications: CNS Therapeutics Maintain a Leading Position among Small Molecule Therapeutics

http://pubs.acs.org/....1021/cn500063v (full article, freely available)

With total 2013 annual sales of $23 Billion, it's easy to see why Lilly is freaked out about the $9 Billion loss on the MDL that was just entered. (See article I posted earlier this evening.) That's almost 1/2 of their annual total sales for last year.

Granted, that amount will likely be reduced somewhat by further legal proceedings, and will be apportioned with the co-defendant Takeda, but it's still going to be a huge kick in the butt. :D

Table 1. Top 20 Global Prescription Drugs in Terms of Sales in 2013

rank product sales(US $ Bn)

1     Humira        9.85
2     Seretide      9.21
3     Crestor       8.14
4     Enbrel        7.94
5     Lantus        7.93
6     Nexium      7.86
7    Abilify          7.83
8    Remicade   7.67
9    Cymbalta    6.46
10  MabThera   6.26
11   Avastin       5.71
12   Spiriva       5.31
13   Herceptin   5.17
14   Lyrica         5.12
15  Copaxone   4.69
16  Januvia       4.46
17  Lucentis      4.41
18  Neulasta     4.40
19  Glivec         4.13
20  Atripla         4.01


Table 3. Top 10 Global Pharmaceutical Corporations in 2013 in Terms of Sales(1)

rank company sales (US$Bn) 2013 growth (%)

1 Novartis                   50.5                +1.9
2 Pfizer                       44.3                –2.6
3 Sanofi-Aventis          38.1               +1.4
4 Merck & Co.            36.3                –7.0
5 Roche                     36.1                +5.3
6 GlaxoSmithKline     32.5                 +1.5
7 Johnson &Johnson 30.7               +12.2
8 AstraZeneca           30.2                 –2.9
9 Teva                       24.2                 –1.8
10 Eli Lilly                 23.0                  +8.4
 


#2 fishinghat

fishinghat

    God-like

  • Active Members
  • PipPipPipPipPipPipPipPip
  • 10,753 posts
  • LocationMissouri

Posted 17 September 2014 - 07:43 AM

Interesting. There are some real nasty drugs on that first list. I am sure that noe Cymbalta has generic composition than Eli Lilley will rank a lot lower when this year's numbers come out.


#3 FiveNotions

FiveNotions

    God-like

  • Active Members
  • PipPipPipPipPipPipPipPip
  • 3,686 posts
  • LocationUS, East Coast
  • why_joining:
    I want my life back!

Posted 17 September 2014 - 08:22 AM

Well, I'm checking on what Lilly's got "up their product sleeve" to throw at us next ... apparently, they think they've got another "blockbuster" or two .... I'll post as soon as I track down some info....


#4 BelaLugosisDad

BelaLugosisDad

    Good Friend

  • Active Members
  • PipPipPipPip
  • 134 posts

Posted 19 September 2014 - 11:40 AM

Just think of these numbers. Sic BILLION dollars. BILLION. Say it in a doctor evil voice.

 

What is going on in Pharma and medicine. Are we all insane, or what?





0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users